Ocular Therapeutix

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

MedPharm

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

CRMG- Clinical Research Management Group

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Human Care Systems

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Berlinger & Co. AG

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Lyne Laboratories

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

LLX Solutions

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

CONTINUUS Pharmaceuticals

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Algeta ASA

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Syros Pharmaceuticals

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Opus Regulatory

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Boston Oncology

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Sumitomo Pharma America Holdings

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Biofrontera Group

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

ONO PHARMA USA

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Armstrong Pharmaceuticals

Pharmaceuticals

United States, Massachusetts

$10M to $25M

51-200

Vita Data Sciences

Pharmaceuticals

United States, Massachusetts

$5M to $10M

51-200

PepTech

Pharmaceuticals

United States, Massachusetts

$5M to $10M

51-200

Santhera Pharmaceuticals

Pharmaceuticals

United States, Massachusetts

$5M to $10M

51-200

Berkshire Sterile Manufacturing

Pharmaceuticals

United States, Massachusetts

$1M to $5M

51-200